OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

oncNGS Summer Update

oncNGS Summer Update
2021-08-13
by Editorial team

As planned, in June we finalized the Open Market Consultation (OMC) and provided the FAQ on our website.

As the OMC is closed, we cannot have direct contacts with any of the suppliers.

If you have any doubt or question on the oncNGS PCP procedure, please check our FAQ page and, in case you feel your inquiry is not being addressed yet, do not hesitate to communicate it to us via our Contact page. We will then formulate an answer and communicate our response trough the FAQ.

We are now in the process to finalize our “Request for tender”, whose contract notice should be published by the end of October through the Official Journal of the European Union.

We advise all the interested economic operators to take advantage of this period to review the material that was made available for the OMC (the slides of the presentation or the video of the event) and to take advantage of the partner search matchmaking page.

We hope you all are as excited as we are about the oncNGS project and are very keen to receive all your responses to this most innovative challenge

Marc Van den Bulcke

Coordinator oncNGS PCP

Share us on:

Articles récents

  • Special Communication on oncNGS PCP published in ESMO Open
  • OncNGS enters Phase 3 of the PCP with two innovative solutions for cancer NGS testing
  • oncNGS consortium conducted site visits to phase 2 contractors
  • OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer
  • Update on the current stage of the oncNGS Pre-Commercial Procurement procedure

Archives

  • mai 2025
  • janvier 2025
  • mai 2024
  • septembre 2023
  • février 2023
  • juillet 2022
  • juin 2022
  • mars 2022
  • janvier 2022
  • décembre 2021
  • novembre 2021
  • septembre 2021
  • août 2021
  • juin 2021
  • mai 2021
  • avril 2021
  • mars 2021

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer